Thus, the present study aimed to determine the clinicopathological significance of GLP-1R in CCA using tumor tissues from patients in Ov-endemic regions and to investigate the roles of liraglutide, a GLP-1R agonist widely used in patients with DM. Here, GLP1R is linked to cholangiocarcinoma.